Work

Synthesis, Anticancer Evaluation, and In Silico Docking Studies of 1-[(1-Phenyl-1H-1,2,3-triazol-5-yl)methyl]-4-(pyridin-2-yl)piperazine Hybrids as Potential MCF Antagonists